AIRLINK 205.81 Increased By ▲ 5.52 (2.76%)
BOP 10.24 Decreased By ▼ -0.25 (-2.38%)
CNERGY 7.06 Decreased By ▼ -0.15 (-2.08%)
FCCL 34.66 Decreased By ▼ -0.28 (-0.8%)
FFL 17.10 Decreased By ▼ -0.32 (-1.84%)
FLYNG 24.68 Decreased By ▼ -0.17 (-0.68%)
HUBC 131.18 Increased By ▲ 3.37 (2.64%)
HUMNL 13.98 Increased By ▲ 0.17 (1.23%)
KEL 4.91 Decreased By ▼ -0.09 (-1.8%)
KOSM 6.81 Decreased By ▼ -0.22 (-3.13%)
MLCF 44.34 Decreased By ▼ -0.28 (-0.63%)
OGDC 221.77 Decreased By ▼ -0.38 (-0.17%)
PACE 7.22 Decreased By ▼ -0.20 (-2.7%)
PAEL 42.69 Decreased By ▼ -0.11 (-0.26%)
PIAHCLA 17.13 Decreased By ▼ -0.26 (-1.5%)
PIBTL 8.42 Decreased By ▼ -0.09 (-1.06%)
POWER 9.09 Decreased By ▼ -0.06 (-0.66%)
PPL 190.86 Decreased By ▼ -1.87 (-0.97%)
PRL 43.49 Increased By ▲ 1.99 (4.8%)
PTC 24.79 Increased By ▲ 0.35 (1.43%)
SEARL 102.66 Increased By ▲ 1.39 (1.37%)
SILK 1.02 Decreased By ▼ -0.03 (-2.86%)
SSGC 42.74 Decreased By ▼ -1.13 (-2.58%)
SYM 18.40 Decreased By ▼ -0.36 (-1.92%)
TELE 9.26 Decreased By ▼ -0.28 (-2.94%)
TPLP 13.15 Increased By ▲ 0.07 (0.54%)
TRG 68.78 Increased By ▲ 2.59 (3.91%)
WAVESAPP 10.42 Decreased By ▼ -0.11 (-1.04%)
WTL 1.80 Increased By ▲ 0.02 (1.12%)
YOUW 4.00 Decreased By ▼ -0.04 (-0.99%)
BR100 12,034 Decreased By -5.6 (-0.05%)
BR30 36,777 Increased By 88.7 (0.24%)
KSE100 114,496 Decreased By -308.5 (-0.27%)
KSE30 36,003 Decreased By -99.2 (-0.27%)

Researchers in the United States say they have developed a prototype blood test that can tell with 90-percent accuracy whether a healthy person will develop Alzheimer's disease within three years. The test looks for 10 signatures of fatty proteins called lipids, according to a study published on March 09 in the journal Nature Medicine.
It could help families of people developing the cognitive disorder make early decisions on how best to care for them and may also aid the search for treatment, the authors said.
Several years of clinical trials are likely to be needed to assess the prototype technique, the first blood "biomarker" to predict the tragic degenerative disease. Alzheimer's, caused by toxic proteins that destroy brain cells, is a currently incurable and fatal degenerative disease.
Around 35 million people have the disease, a tally that is expected to reach 115 million people by 2050, according to the World Health Organisation.
"Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder," said Howard Federoff, a professor of neurology at Georgetown University Medical Center in Washington.
It could also help efforts to treat the disease, he said in a press release.
Attempts to develop drugs for Alzheimer's have failed possibly because they are tested when the disease has progressed too far, Federoff said.
These treatments may have a better chance of braking or reversing the disease if they are trialled at a much earlier stage, he said.
The researchers started by taking blood samples from 525 healthy volunteers aged 70 and older.
Three years later, they looked at a group of 53 volunteers who had developed symptoms of early Alzheimer's or a memory-affecting condition known as amnestic mild cognitive impairment (aMCI).
The blood samples from this group were compared against the samples from 53 otherwise healthy volunteers to see what the difference was.
From this, the scientists spotted the 10 telltale lipid proteins, which appear to be metabolised residues of brain cell membranes.

Copyright Agence France-Presse, 2014

Comments

Comments are closed.